>
COMMANDS Global: GP Symbol: IBM FA
↑↓ Navigate Enter Open Esc Close ` Toggle

CompanyHeadlineTime (ET)
SONSonoco To Report First Quarter 2026 Results04/17 16:10
IHFIHF: Healthcare Dashboard For April04/17 16:08
LUROSEN, LEADING INVESTOR COUNSEL, Encourages Lufax Holding Ltd Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - LU04/17 16:08
PHOSFirst Phosphate secures €170M mine funding boost – ICYMI04/17 16:06
PGREParamount Declares Quarterly Cash Dividend04/17 16:05
ALXALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules04/17 16:05
LAESSEALSQ Announces Agenda of its 2026 Annual General Meeting of Shareholders04/17 16:05
TOVXTheriva™ Biologics Announces Upcoming Presentation of Additional Data from the VIRAGE Phase 2b Clinical Trial of VCN-01 in Metastatic Pancreatic Cancer at AACR 2026 Annual Meeting04/17 16:05
TLNTalen Energy Announces Pricing of Senior Notes04/17 16:05
CAMPCAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)04/17 16:05
ORICORIC® Pharmaceuticals Presents Preclinical Data to Support the Potential of Rinzimetostat Across Prostate Cancer and in Emerging Resistance Settings at the 2026 American Association for Cancer Research (AACR) Annual Meeting04/17 16:05
VRAVera Bradley Terminates Existing Shareholder Rights Plan04/17 16:05
PYXSPyxis Oncology to Present New Preclinical Data Showing Synergistic Anti-Tumor Activity in a HNSCC model with maMICVO in Combination with Anti-PD-1 at AACR 202604/17 16:05
CRWVCoreWeave Announces Date of First Quarter 2026 Financial Results and Conference Call04/17 16:05
GDRXGoodRx Announces Date for First Quarter 2026 Earnings Release and Conference Call04/17 16:05
FIXComfort Systems USA Announces First Quarter 2026 Conference Call and Webcast04/17 16:05
SVRASavara Announces New Employment Inducement Grant04/17 16:05
BMIBadger Meter: Finally A Buy Following Q1 Earnings Tumble04/17 16:04
TXNThis Hedge Fund-Favored Semi Stock is on the Cusp of a Multi-Year Breakout04/17 16:04
RVMDRevolution Medicines Announces Closing of Concurrent Upsized Public Offerings with Aggregate Gross Proceeds of Approximately $2.2 Billion, Including Full Exercise of Underwriters' Option to Purchase Additional Shares04/17 16:02

Market News ×
Loading news…